AI assistant
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2007
Mar 5, 2007
35599_dirs_2007-03-05_ffb55f29-4a83-4290-a911-06d89ae98b47.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ADHEREX TECHNOLOGIES INC (AMEX:ADH)
CIK: 0001211583
Period of Report: 2007-02-21
Reporting Person: NORRIS ROBIN J (Director, President & COO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 8100 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to buy) | $.28 | 2014-02-28 | Common Stock (75000) | Direct | |
| Stock Options (Right to buy) | $.88 | 2012-12-14 | Common Stock (45000) | Direct | |
| Stock Options (Right to buy) | $1.2 | 2012-09-21 | Common Stock (15000) | Direct | |
| Stock Options (Right to buy) | $1.65 | 2008-12-12 | Common Stock (120000) | Direct | |
| Stock Options (Right to buy) | $1.7 | 2010-05-03 | Common Stock (40000) | Direct | |
| Stock Options (Right to buy) | $2.25 | 2010-12-30 | Common Stock (75600) | Direct | |
| Stock Options (Right to buy) | $2.9 | 2011-05-21 | Common Stock (36400) | Direct |
Footnotes
F1: The options to which this note relates are subject to vesting in three (3) installments with one-third vesting immediately and the remaining shares vesting on the first and second anniversary of the Grant Date reported above.
F4: The options to which this note relates are subject to vesting in three (3) installments with (i) 10,000 vesting on 12/11/2004(ii) 14,266 shares vesting on 5/21/2005; and (iii) the remaining shares vesting on 5/21/2006.
F2: The options to which this note relates vest in three (3) equal installments beginning on the date reported above.
F3: Exercise price for these options are in Canadian Dollars.